Skip to main content

Fiscal Wizard · Single-issue tearsheet

STVN / Jun 20, 2026 Run #7227

STVN

Stevanato Group S.p.A.

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprising pre-fillable syringes, cartridges, vials, and ampoules; in-vitro diagnostic solutions; drug delivery systems, including pen injectors, auto-injectors, and wearable injectors; diagnostic laboratory consumables; analytical and regulatory support services; medical devices; pharmaceutical visual inspection machines; assembling and packaging machines; glass converting machines; and after-sales services, such as line optimization and line conversions, training, logistics, spare parts and maintenance services. It also provides contract development and manufacturing services for customer-owned drug delivery devices. The company serves pharmaceutical, biotechnology, diagnostics, and life sciences companies; and drug products, glass packaging, and fill and finish contract manufacturers. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.

Composite verdict

F 18.3 / 100
Bearish setup · Reversal 12 drivers · 4 gates blocking
  • Double 7s
  • Vortex Signal
  • Sushi Roll
Consider long put target Δ ~0.70 · ~35 DTE Bearish setup, Grade A → ITM put target

Industry rank 37th of 57 in Medical Instruments & Supplies

rescore-sweep
Technical synthesisRegime: range
Bull 0%Evidence: High · 22 signals100% Bear
Momentum Bearish 7Mean-reversion Neutral 44

No notable composite patterns — the signals don't cluster into a named setup right now.

Where value comes fromMargin of safety -62%
Asset value $29.90Earnings power value $26.05Price $17.54

Trading below its asset value ($29.90/share) — deep value, but check for a melting balance sheet.

Fundamentals Weak

36.5 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
Return on Assets 75
Margin of Safety 0
EBITDA Margin 75
EV/FCF 0
Return on Capital Employed 75
OCF to Net Income 0

Technicals Bearish

0.0 / 100

Bearish setup leads (Double 7s, Vortex Signal, Sushi Roll); bulls gated by guards. · 43 signals shown.

Strongest
Weakest
Double 7s 12
Rate of Change 13
Vortex Signal 14

Risk Gates

4 blocking 1 caution

4 guards active, 16 signals gated.

ADX Trend Weakness Blocking

Weak trend strength blocks trend-following signals in either direction.

MA Crossover Blocking

Blocks counter-regime signals only when the MA crossover agrees with the long-term regime.

Realized Volatility Regime Blocking

High-vol regime mutes mean-reversion signals; low-vol regime mutes breakout signals.

Regime Filter Blocking

Blocks signals that oppose the long-term moving-average regime.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for STVN.